Skip to main
CL

Colgate-Palmolive (CL) Stock Forecast & Price Target

Colgate-Palmolive (CL) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 35%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Colgate-Palmolive is a well-established company with a strong position in the household and personal care industry. With a strong history of over 200 years, the company has shown its ability to adapt and innovate in a rapidly changing market. Its diverse product portfolio, particularly its leading oral care and pet food brands, provides a solid foundation for growth in emerging markets, where it has a significant presence. While short-term volatility remains a concern, the company's locked-in costs, cost-saving initiatives, and sustainable practices bode well for its long-term growth potential. With an expected +2-3% organic sales growth and +6-7% EPS growth in 2026-28, we maintain a positive outlook on the stock, with a target of $92 (~22.0x our 2027E EPS of $4.15).

Bears say

Colgate-Palmolive is a well-established company with strong global reach in the household and personal care industry. However, recent macro pressures, volatility in emerging market currencies, and increased competitive activity in its core markets could hinder its target organic sales growth of +3-5%. Additionally, there are risks related to volatility in input costs and potential recessionary pressures, which could impact profitability. While the company has a consistent track record of delivering against its targets, it may face challenges in achieving its long-term goals due to these external factors.

Colgate-Palmolive (CL) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 35% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Colgate-Palmolive and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Colgate-Palmolive (CL) Forecast

Analysts have given Colgate-Palmolive (CL) a Buy based on their latest research and market trends.

According to 17 analysts, Colgate-Palmolive (CL) has a Buy consensus rating as of Aug 13, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $97.82, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $97.82, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Colgate-Palmolive (CL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.